Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04094675 · ClinicalTrials.gov registry record · Phase 2
Sirolimus for Cowden Syndrome With Colon Polyposis
A Phase 2 study, sponsored by Ohio State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT04094675 is a Phase 2 study that has completed, run by Ohio State University. The registered enrollment target is 5 participants.
The verdict
NCT04094675, a Phase 2 study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
Colon polyposis (the presence of multiple colon polyps) is very common with Cowden syndrome, as over 60% of patients have 50 or more polyps. In a previous clinical trial, some participants had reduction in the number of colon polyps with the use of the medication sirolimus for a very short time period. This study is investigating sirolimus and its effect on the number of colon polyps in patients with Cowden syndrome and polyposis over a 1 year period.
Interventions
- DRUG Sirolimus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2019-09-16 |
| Est. Completion | 2025-06-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04094675
The ClinicalTrials.gov registry entry for NCT04094675 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sirolimus is the first listed.
NCT04094675 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04094675 about?
NCT04094675 is a clinical study titled "Sirolimus for Cowden Syndrome With Colon Polyposis". Colon polyposis (the presence of multiple colon polyps) is very common with Cowden syndrome, as over 60% of patients have 50 or more polyps. In a previous clinical trial, some participants had reduction in the number of colon polyps with the use of the medication sirolimus for a very short time peri...
What is the current status of trial NCT04094675?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2019-09-16. Estimated completion is 2025-06-05.
What interventions are being tested in trial NCT04094675?
The interventions under investigation include: Sirolimus (DRUG).
Who is sponsoring clinical trial NCT04094675?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.